RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 126 - per page Previous page Next page
Order by
Transdermal pain patch for the treatment of moderate to severe chronic pain. More
Superior Alternative to Pads and Tampons More
Our client company has developed an innovative frozen lozenge technology designed to deliver pharmaceuticals and OTC products, which offers a new alternative administration method for paediatric and otherwise difficult to swallow therapeutics. More
The First Line of Therapy in Severe Migraine Attacks More
The development of a transdermal therapeutic system offers the advantages of constant plasma levels i.e. avoiding of plasma peaks and providing of therapeutic plasma level during the early morning hours More
Indicated for the treatment and prevention of diabetic foot ulcers. More
5 and 10 mg Donepezil are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
4 and 8 mg Ondansetron ready for submission in EU (exp. Q4/08) using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
25mg dosage strenght for the OTC market More
5, 10 and 15 mg drug substance Olanzapine uses oral film dosage form dissolving within seconds without need of water More
Displaying 11..20 of 126 - per page Previous page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us